 | • レポートコード：MRC2-11QY13304 • 出版社/出版日：QYResearch / 2020年11月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、116ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はウィルムス腫瘍タンパク質のグローバル市場について調査・分析したレポートです。種類別（エラチペプムト-S、ガリンペピムット-S、GSK-2130579A、INO-5401、OCV-501、その他）市場規模、用途別（副腎がん、高悪性度神経膠腫、肺がん、腹膜がん、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別ウィルムス腫瘍タンパク質の競争状況、市場シェア ・世界のウィルムス腫瘍タンパク質市場：種類別市場規模 2015年-2020年（エラチペプムト-S、ガリンペピムット-S、GSK-2130579A、INO-5401、OCV-501、その他） ・世界のウィルムス腫瘍タンパク質市場：種類別市場規模予測 2021年-2026年（エラチペプムト-S、ガリンペピムット-S、GSK-2130579A、INO-5401、OCV-501、その他） ・世界のウィルムス腫瘍タンパク質市場：用途別市場規模 2015年-2020年（副腎がん、高悪性度神経膠腫、肺がん、腹膜がん、その他） ・世界のウィルムス腫瘍タンパク質市場：用途別市場規模予測 2021年-2026年（副腎がん、高悪性度神経膠腫、肺がん、腹膜がん、その他） ・北米のウィルムス腫瘍タンパク質市場分析：米国、カナダ ・ヨーロッパのウィルムス腫瘍タンパク質市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのウィルムス腫瘍タンパク質市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のウィルムス腫瘍タンパク質市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのウィルムス腫瘍タンパク質市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：GlaxoSmithKline Plc、Inovio Pharmaceuticals Inc、Otsuka Holdings Co Ltd、Sellas Life Sciences Group Ltd、Sumitomo Dainippon Pharma Co Ltd、Vaximm AG ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Wilms Tumor Protein Market
The global Wilms Tumor Protein market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Wilms Tumor Protein Scope and Market Size
Wilms Tumor Protein market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Wilms Tumor Protein market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Wilms Tumor Protein market is segmented into
Elatipepimut-S
Galinpepimut-S
GSK-2130579A
INO-5401
OCV-501
Others
Segment by Application, the Wilms Tumor Protein market is segmented into
Adrenal Gland Cancer
High-Grade Glioma
Lung Cancer
Peritoneal Cancer
Others
Regional and Country-level Analysis
The Wilms Tumor Protein market is analysed and market size information is provided by regions (countries).
The key regions covered in the Wilms Tumor Protein market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Wilms Tumor Protein Market Share Analysis
Wilms Tumor Protein market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Wilms Tumor Protein business, the date to enter into the Wilms Tumor Protein market, Wilms Tumor Protein product introduction, recent developments, etc.
The major vendors covered:
GlaxoSmithKline Plc
Inovio Pharmaceuticals Inc
Otsuka Holdings Co Ltd
Sellas Life Sciences Group Ltd
Sumitomo Dainippon Pharma Co Ltd
Vaximm AG
…
1 Study Coverage
1.1 Wilms Tumor Protein Product Introduction
1.2 Market Segments
1.3 Key Wilms Tumor Protein Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Wilms Tumor Protein Market Size Growth Rate by Type
1.4.2 Elatipepimut-S
1.4.3 Galinpepimut-S
1.4.4 GSK-2130579A
1.4.5 INO-5401
1.4.6 OCV-501
1.4.7 Others
1.5 Market by Application
1.5.1 Global Wilms Tumor Protein Market Size Growth Rate by Application
1.5.2 Adrenal Gland Cancer
1.5.3 High-Grade Glioma
1.5.4 Lung Cancer
1.5.5 Peritoneal Cancer
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Wilms Tumor Protein Market Size, Estimates and Forecasts
2.1.1 Global Wilms Tumor Protein Revenue 2015-2026
2.1.2 Global Wilms Tumor Protein Sales 2015-2026
2.2 Global Wilms Tumor Protein, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Wilms Tumor Protein Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Wilms Tumor Protein Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Wilms Tumor Protein Competitor Landscape by Players
3.1 Wilms Tumor Protein Sales by Manufacturers
3.1.1 Wilms Tumor Protein Sales by Manufacturers (2015-2020)
3.1.2 Wilms Tumor Protein Sales Market Share by Manufacturers (2015-2020)
3.2 Wilms Tumor Protein Revenue by Manufacturers
3.2.1 Wilms Tumor Protein Revenue by Manufacturers (2015-2020)
3.2.2 Wilms Tumor Protein Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Wilms Tumor Protein Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Wilms Tumor Protein Revenue in 2019
3.2.5 Global Wilms Tumor Protein Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Wilms Tumor Protein Price by Manufacturers
3.4 Wilms Tumor Protein Manufacturing Base Distribution, Product Types
3.4.1 Wilms Tumor Protein Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Wilms Tumor Protein Product Type
3.4.3 Date of International Manufacturers Enter into Wilms Tumor Protein Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Wilms Tumor Protein Market Size by Type (2015-2020)
4.1.1 Global Wilms Tumor Protein Sales by Type (2015-2020)
4.1.2 Global Wilms Tumor Protein Revenue by Type (2015-2020)
4.1.3 Wilms Tumor Protein Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Wilms Tumor Protein Market Size Forecast by Type (2021-2026)
4.2.1 Global Wilms Tumor Protein Sales Forecast by Type (2021-2026)
4.2.2 Global Wilms Tumor Protein Revenue Forecast by Type (2021-2026)
4.2.3 Wilms Tumor Protein Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Wilms Tumor Protein Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Wilms Tumor Protein Market Size by Application (2015-2020)
5.1.1 Global Wilms Tumor Protein Sales by Application (2015-2020)
5.1.2 Global Wilms Tumor Protein Revenue by Application (2015-2020)
5.1.3 Wilms Tumor Protein Price by Application (2015-2020)
5.2 Wilms Tumor Protein Market Size Forecast by Application (2021-2026)
5.2.1 Global Wilms Tumor Protein Sales Forecast by Application (2021-2026)
5.2.2 Global Wilms Tumor Protein Revenue Forecast by Application (2021-2026)
5.2.3 Global Wilms Tumor Protein Price Forecast by Application (2021-2026)
6 North America
6.1 North America Wilms Tumor Protein by Country
6.1.1 North America Wilms Tumor Protein Sales by Country
6.1.2 North America Wilms Tumor Protein Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Wilms Tumor Protein Market Facts & Figures by Type
6.3 North America Wilms Tumor Protein Market Facts & Figures by Application
7 Europe
7.1 Europe Wilms Tumor Protein by Country
7.1.1 Europe Wilms Tumor Protein Sales by Country
7.1.2 Europe Wilms Tumor Protein Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Wilms Tumor Protein Market Facts & Figures by Type
7.3 Europe Wilms Tumor Protein Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Wilms Tumor Protein by Region
8.1.1 Asia Pacific Wilms Tumor Protein Sales by Region
8.1.2 Asia Pacific Wilms Tumor Protein Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Wilms Tumor Protein Market Facts & Figures by Type
8.3 Asia Pacific Wilms Tumor Protein Market Facts & Figures by Application
9 Latin America
9.1 Latin America Wilms Tumor Protein by Country
9.1.1 Latin America Wilms Tumor Protein Sales by Country
9.1.2 Latin America Wilms Tumor Protein Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Wilms Tumor Protein Market Facts & Figures by Type
9.3 Central & South America Wilms Tumor Protein Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Wilms Tumor Protein by Country
10.1.1 Middle East and Africa Wilms Tumor Protein Sales by Country
10.1.2 Middle East and Africa Wilms Tumor Protein Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Wilms Tumor Protein Market Facts & Figures by Type
10.3 Middle East and Africa Wilms Tumor Protein Market Facts & Figures by Application
11 Company Profiles
11.1 GlaxoSmithKline Plc
11.1.1 GlaxoSmithKline Plc Corporation Information
11.1.2 GlaxoSmithKline Plc Description and Business Overview
11.1.3 GlaxoSmithKline Plc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 GlaxoSmithKline Plc Wilms Tumor Protein Products Offered
11.1.5 GlaxoSmithKline Plc Related Developments
11.2 Inovio Pharmaceuticals Inc
11.2.1 Inovio Pharmaceuticals Inc Corporation Information
11.2.2 Inovio Pharmaceuticals Inc Description and Business Overview
11.2.3 Inovio Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Inovio Pharmaceuticals Inc Wilms Tumor Protein Products Offered
11.2.5 Inovio Pharmaceuticals Inc Related Developments
11.3 Otsuka Holdings Co Ltd
11.3.1 Otsuka Holdings Co Ltd Corporation Information
11.3.2 Otsuka Holdings Co Ltd Description and Business Overview
11.3.3 Otsuka Holdings Co Ltd Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Otsuka Holdings Co Ltd Wilms Tumor Protein Products Offered
11.3.5 Otsuka Holdings Co Ltd Related Developments
11.4 Sellas Life Sciences Group Ltd
11.4.1 Sellas Life Sciences Group Ltd Corporation Information
11.4.2 Sellas Life Sciences Group Ltd Description and Business Overview
11.4.3 Sellas Life Sciences Group Ltd Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Sellas Life Sciences Group Ltd Wilms Tumor Protein Products Offered
11.4.5 Sellas Life Sciences Group Ltd Related Developments
11.5 Sumitomo Dainippon Pharma Co Ltd
11.5.1 Sumitomo Dainippon Pharma Co Ltd Corporation Information
11.5.2 Sumitomo Dainippon Pharma Co Ltd Description and Business Overview
11.5.3 Sumitomo Dainippon Pharma Co Ltd Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Sumitomo Dainippon Pharma Co Ltd Wilms Tumor Protein Products Offered
11.5.5 Sumitomo Dainippon Pharma Co Ltd Related Developments
11.6 Vaximm AG
11.6.1 Vaximm AG Corporation Information
11.6.2 Vaximm AG Description and Business Overview
11.6.3 Vaximm AG Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Vaximm AG Wilms Tumor Protein Products Offered
11.6.5 Vaximm AG Related Developments
11.1 GlaxoSmithKline Plc
11.1.1 GlaxoSmithKline Plc Corporation Information
11.1.2 GlaxoSmithKline Plc Description and Business Overview
11.1.3 GlaxoSmithKline Plc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 GlaxoSmithKline Plc Wilms Tumor Protein Products Offered
11.1.5 GlaxoSmithKline Plc Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Wilms Tumor Protein Market Estimates and Projections by Region
12.1.1 Global Wilms Tumor Protein Sales Forecast by Regions 2021-2026
12.1.2 Global Wilms Tumor Protein Revenue Forecast by Regions 2021-2026
12.2 North America Wilms Tumor Protein Market Size Forecast (2021-2026)
12.2.1 North America: Wilms Tumor Protein Sales Forecast (2021-2026)
12.2.2 North America: Wilms Tumor Protein Revenue Forecast (2021-2026)
12.2.3 North America: Wilms Tumor Protein Market Size Forecast by Country (2021-2026)
12.3 Europe Wilms Tumor Protein Market Size Forecast (2021-2026)
12.3.1 Europe: Wilms Tumor Protein Sales Forecast (2021-2026)
12.3.2 Europe: Wilms Tumor Protein Revenue Forecast (2021-2026)
12.3.3 Europe: Wilms Tumor Protein Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Wilms Tumor Protein Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Wilms Tumor Protein Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Wilms Tumor Protein Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Wilms Tumor Protein Market Size Forecast by Region (2021-2026)
12.5 Latin America Wilms Tumor Protein Market Size Forecast (2021-2026)
12.5.1 Latin America: Wilms Tumor Protein Sales Forecast (2021-2026)
12.5.2 Latin America: Wilms Tumor Protein Revenue Forecast (2021-2026)
12.5.3 Latin America: Wilms Tumor Protein Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Wilms Tumor Protein Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Wilms Tumor Protein Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Wilms Tumor Protein Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Wilms Tumor Protein Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Wilms Tumor Protein Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Wilms Tumor Protein Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Wilms Tumor Protein Market Segments
Table 2. Ranking of Global Top Wilms Tumor Protein Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Wilms Tumor Protein Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Elatipepimut-S
Table 5. Major Manufacturers of Galinpepimut-S
Table 6. Major Manufacturers of GSK-2130579A
Table 7. Major Manufacturers of INO-5401
Table 8. Major Manufacturers of OCV-501
Table 9. Major Manufacturers of Others
Table 10. Global Wilms Tumor Protein Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 11. Global Wilms Tumor Protein Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 12. Global Wilms Tumor Protein Sales by Regions 2015-2020 (K Pcs)
Table 13. Global Wilms Tumor Protein Sales Market Share by Regions (2015-2020)
Table 14. Global Wilms Tumor Protein Revenue by Regions 2015-2020 (US$ Million)
Table 15. Global Wilms Tumor Protein Sales by Manufacturers (2015-2020) (K Pcs)
Table 16. Global Wilms Tumor Protein Sales Share by Manufacturers (2015-2020)
Table 17. Global Wilms Tumor Protein Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 18. Global Wilms Tumor Protein by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Wilms Tumor Protein as of 2019)
Table 19. Wilms Tumor Protein Revenue by Manufacturers (2015-2020) (US$ Million)
Table 20. Wilms Tumor Protein Revenue Share by Manufacturers (2015-2020)
Table 21. Key Manufacturers Wilms Tumor Protein Price (2015-2020) (USD/Pcs)
Table 22. Wilms Tumor Protein Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Wilms Tumor Protein Product Type
Table 24. Date of International Manufacturers Enter into Wilms Tumor Protein Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Wilms Tumor Protein Sales by Type (2015-2020) (K Pcs)
Table 27. Global Wilms Tumor Protein Sales Share by Type (2015-2020)
Table 28. Global Wilms Tumor Protein Revenue by Type (2015-2020) (US$ Million)
Table 29. Global Wilms Tumor Protein Revenue Share by Type (2015-2020)
Table 30. Wilms Tumor Protein Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 31. Global Wilms Tumor Protein Sales by Application (2015-2020) (K Pcs)
Table 32. Global Wilms Tumor Protein Sales Share by Application (2015-2020)
Table 33. North America Wilms Tumor Protein Sales by Country (2015-2020) (K Pcs)
Table 34. North America Wilms Tumor Protein Sales Market Share by Country (2015-2020)
Table 35. North America Wilms Tumor Protein Revenue by Country (2015-2020) (US$ Million)
Table 36. North America Wilms Tumor Protein Revenue Market Share by Country (2015-2020)
Table 37. North America Wilms Tumor Protein Sales by Type (2015-2020) (K Pcs)
Table 38. North America Wilms Tumor Protein Sales Market Share by Type (2015-2020)
Table 39. North America Wilms Tumor Protein Sales by Application (2015-2020) (K Pcs)
Table 40. North America Wilms Tumor Protein Sales Market Share by Application (2015-2020)
Table 41. Europe Wilms Tumor Protein Sales by Country (2015-2020) (K Pcs)
Table 42. Europe Wilms Tumor Protein Sales Market Share by Country (2015-2020)
Table 43. Europe Wilms Tumor Protein Revenue by Country (2015-2020) (US$ Million)
Table 44. Europe Wilms Tumor Protein Revenue Market Share by Country (2015-2020)
Table 45. Europe Wilms Tumor Protein Sales by Type (2015-2020) (K Pcs)
Table 46. Europe Wilms Tumor Protein Sales Market Share by Type (2015-2020)
Table 47. Europe Wilms Tumor Protein Sales by Application (2015-2020) (K Pcs)
Table 48. Europe Wilms Tumor Protein Sales Market Share by Application (2015-2020)
Table 49. Asia Pacific Wilms Tumor Protein Sales by Region (2015-2020) (K Pcs)
Table 50. Asia Pacific Wilms Tumor Protein Sales Market Share by Region (2015-2020)
Table 51. Asia Pacific Wilms Tumor Protein Revenue by Region (2015-2020) (US$ Million)
Table 52. Asia Pacific Wilms Tumor Protein Revenue Market Share by Region (2015-2020)
Table 53. Asia Pacific Wilms Tumor Protein Sales by Type (2015-2020) (K Pcs)
Table 54. Asia Pacific Wilms Tumor Protein Sales Market Share by Type (2015-2020)
Table 55. Asia Pacific Wilms Tumor Protein Sales by Application (2015-2020) (K Pcs)
Table 56. Asia Pacific Wilms Tumor Protein Sales Market Share by Application (2015-2020)
Table 57. Latin America Wilms Tumor Protein Sales by Country (2015-2020) (K Pcs)
Table 58. Latin America Wilms Tumor Protein Sales Market Share by Country (2015-2020)
Table 59. Latin Americaa Wilms Tumor Protein Revenue by Country (2015-2020) (US$ Million)
Table 60. Latin America Wilms Tumor Protein Revenue Market Share by Country (2015-2020)
Table 61. Latin America Wilms Tumor Protein Sales by Type (2015-2020) (K Pcs)
Table 62. Latin America Wilms Tumor Protein Sales Market Share by Type (2015-2020)
Table 63. Latin America Wilms Tumor Protein Sales by Application (2015-2020) (K Pcs)
Table 64. Latin America Wilms Tumor Protein Sales Market Share by Application (2015-2020)
Table 65. Middle East and Africa Wilms Tumor Protein Sales by Country (2015-2020) (K Pcs)
Table 66. Middle East and Africa Wilms Tumor Protein Sales Market Share by Country (2015-2020)
Table 67. Middle East and Africa Wilms Tumor Protein Revenue by Country (2015-2020) (US$ Million)
Table 68. Middle East and Africa Wilms Tumor Protein Revenue Market Share by Country (2015-2020)
Table 69. Middle East and Africa Wilms Tumor Protein Sales by Type (2015-2020) (K Pcs)
Table 70. Middle East and Africa Wilms Tumor Protein Sales Market Share by Type (2015-2020)
Table 71. Middle East and Africa Wilms Tumor Protein Sales by Application (2015-2020) (K Pcs)
Table 72. Middle East and Africa Wilms Tumor Protein Sales Market Share by Application (2015-2020)
Table 73. GlaxoSmithKline Plc Corporation Information
Table 74. GlaxoSmithKline Plc Description and Major Businesses
Table 75. GlaxoSmithKline Plc Wilms Tumor Protein Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 76. GlaxoSmithKline Plc Product
Table 77. GlaxoSmithKline Plc Recent Development
Table 78. Inovio Pharmaceuticals Inc Corporation Information
Table 79. Inovio Pharmaceuticals Inc Description and Major Businesses
Table 80. Inovio Pharmaceuticals Inc Wilms Tumor Protein Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 81. Inovio Pharmaceuticals Inc Product
Table 82. Inovio Pharmaceuticals Inc Recent Development
Table 83. Otsuka Holdings Co Ltd Corporation Information
Table 84. Otsuka Holdings Co Ltd Description and Major Businesses
Table 85. Otsuka Holdings Co Ltd Wilms Tumor Protein Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 86. Otsuka Holdings Co Ltd Product
Table 87. Otsuka Holdings Co Ltd Recent Development
Table 88. Sellas Life Sciences Group Ltd Corporation Information
Table 89. Sellas Life Sciences Group Ltd Description and Major Businesses
Table 90. Sellas Life Sciences Group Ltd Wilms Tumor Protein Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 91. Sellas Life Sciences Group Ltd Product
Table 92. Sellas Life Sciences Group Ltd Recent Development
Table 93. Sumitomo Dainippon Pharma Co Ltd Corporation Information
Table 94. Sumitomo Dainippon Pharma Co Ltd Description and Major Businesses
Table 95. Sumitomo Dainippon Pharma Co Ltd Wilms Tumor Protein Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 96. Sumitomo Dainippon Pharma Co Ltd Product
Table 97. Sumitomo Dainippon Pharma Co Ltd Recent Development
Table 98. Vaximm AG Corporation Information
Table 99. Vaximm AG Description and Major Businesses
Table 100. Vaximm AG Wilms Tumor Protein Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 101. Vaximm AG Product
Table 102. Vaximm AG Recent Development
Table 103. Global Wilms Tumor Protein Sales Forecast by Regions (2021-2026) (K Pcs)
Table 104. Global Wilms Tumor Protein Sales Market Share Forecast by Regions (2021-2026)
Table 105. Global Wilms Tumor Protein Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 106. Global Wilms Tumor Protein Revenue Market Share Forecast by Regions (2021-2026)
Table 107. North America: Wilms Tumor Protein Sales Forecast by Country (2021-2026) (K Pcs)
Table 108. North America: Wilms Tumor Protein Revenue Forecast by Country (2021-2026) (US$ Million)
Table 109. Europe: Wilms Tumor Protein Sales Forecast by Country (2021-2026) (K Pcs)
Table 110. Europe: Wilms Tumor Protein Revenue Forecast by Country (2021-2026) (US$ Million)
Table 111. Asia Pacific: Wilms Tumor Protein Sales Forecast by Region (2021-2026) (K Pcs)
Table 112. Asia Pacific: Wilms Tumor Protein Revenue Forecast by Region (2021-2026) (US$ Million)
Table 113. Latin America: Wilms Tumor Protein Sales Forecast by Country (2021-2026) (K Pcs)
Table 114. Latin America: Wilms Tumor Protein Revenue Forecast by Country (2021-2026) (US$ Million)
Table 115. Middle East and Africa: Wilms Tumor Protein Sales Forecast by Country (2021-2026) (K Pcs)
Table 116. Middle East and Africa: Wilms Tumor Protein Revenue Forecast by Country (2021-2026) (US$ Million)
Table 117. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 118. Key Challenges
Table 119. Market Risks
Table 120. Main Points Interviewed from Key Wilms Tumor Protein Players
Table 121. Wilms Tumor Protein Customers List
Table 122. Wilms Tumor Protein Distributors List
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Wilms Tumor Protein Product Picture
Figure 2. Global Wilms Tumor Protein Sales Market Share by Type in 2020 & 2026
Figure 3. Elatipepimut-S Product Picture
Figure 4. Galinpepimut-S Product Picture
Figure 5. GSK-2130579A Product Picture
Figure 6. INO-5401 Product Picture
Figure 7. OCV-501 Product Picture
Figure 8. Others Product Picture
Figure 9. Global Wilms Tumor Protein Sales Market Share by Application in 2020 & 2026
Figure 10. Adrenal Gland Cancer
Figure 11. High-Grade Glioma
Figure 12. Lung Cancer
Figure 13. Peritoneal Cancer
Figure 14. Others
Figure 15. Wilms Tumor Protein Report Years Considered
Figure 16. Global Wilms Tumor Protein Market Size 2015-2026 (US$ Million)
Figure 17. Global Wilms Tumor Protein Sales 2015-2026 (K Pcs)
Figure 18. Global Wilms Tumor Protein Market Size Market Share by Region: 2020 Versus 2026
Figure 19. Global Wilms Tumor Protein Sales Market Share by Region (2015-2020)
Figure 20. Global Wilms Tumor Protein Sales Market Share by Region in 2019
Figure 21. Global Wilms Tumor Protein Revenue Market Share by Region (2015-2020)
Figure 22. Global Wilms Tumor Protein Revenue Market Share by Region in 2019
Figure 23. Global Wilms Tumor Protein Sales Share by Manufacturer in 2019
Figure 24. The Top 10 and 5 Players Market Share by Wilms Tumor Protein Revenue in 2019
Figure 25. Wilms Tumor Protein Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 26. Global Wilms Tumor Protein Sales Market Share by Type (2015-2020)
Figure 27. Global Wilms Tumor Protein Sales Market Share by Type in 2019
Figure 28. Global Wilms Tumor Protein Revenue Market Share by Type (2015-2020)
Figure 29. Global Wilms Tumor Protein Revenue Market Share by Type in 2019
Figure 30. Global Wilms Tumor Protein Market Share by Price Range (2015-2020)
Figure 31. Global Wilms Tumor Protein Sales Market Share by Application (2015-2020)
Figure 32. Global Wilms Tumor Protein Sales Market Share by Application in 2019
Figure 33. Global Wilms Tumor Protein Revenue Market Share by Application (2015-2020)
Figure 34. Global Wilms Tumor Protein Revenue Market Share by Application in 2019
Figure 35. North America Wilms Tumor Protein Sales Growth Rate 2015-2020 (K Pcs)
Figure 36. North America Wilms Tumor Protein Revenue Growth Rate 2015-2020 (US$ Million)
Figure 37. North America Wilms Tumor Protein Sales Market Share by Country in 2019
Figure 38. North America Wilms Tumor Protein Revenue Market Share by Country in 2019
Figure 39. U.S. Wilms Tumor Protein Sales Growth Rate (2015-2020) (K Pcs)
Figure 40. U.S. Wilms Tumor Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. Canada Wilms Tumor Protein Sales Growth Rate (2015-2020) (K Pcs)
Figure 42. Canada Wilms Tumor Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. North America Wilms Tumor Protein Market Share by Type in 2019
Figure 44. North America Wilms Tumor Protein Market Share by Application in 2019
Figure 45. Europe Wilms Tumor Protein Sales Growth Rate 2015-2020 (K Pcs)
Figure 46. Europe Wilms Tumor Protein Revenue Growth Rate 2015-2020 (US$ Million)
Figure 47. Europe Wilms Tumor Protein Sales Market Share by Country in 2019
Figure 48. Europe Wilms Tumor Protein Revenue Market Share by Country in 2019
Figure 49. Germany Wilms Tumor Protein Sales Growth Rate (2015-2020) (K Pcs)
Figure 50. Germany Wilms Tumor Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. France Wilms Tumor Protein Sales Growth Rate (2015-2020) (K Pcs)
Figure 52. France Wilms Tumor Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. U.K. Wilms Tumor Protein Sales Growth Rate (2015-2020) (K Pcs)
Figure 54. U.K. Wilms Tumor Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Italy Wilms Tumor Protein Sales Growth Rate (2015-2020) (K Pcs)
Figure 56. Italy Wilms Tumor Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Russia Wilms Tumor Protein Sales Growth Rate (2015-2020) (K Pcs)
Figure 58. Russia Wilms Tumor Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Europe Wilms Tumor Protein Market Share by Type in 2019
Figure 60. Europe Wilms Tumor Protein Market Share by Application in 2019
Figure 61. Asia Pacific Wilms Tumor Protein Sales Growth Rate 2015-2020 (K Pcs)
Figure 62. Asia Pacific Wilms Tumor Protein Revenue Growth Rate 2015-2020 (US$ Million)
Figure 63. Asia Pacific Wilms Tumor Protein Sales Market Share by Region in 2019
Figure 64. Asia Pacific Wilms Tumor Protein Revenue Market Share by Region in 2019
Figure 65. China Wilms Tumor Protein Sales Growth Rate (2015-2020) (K Pcs)
Figure 66. China Wilms Tumor Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Japan Wilms Tumor Protein Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. Japan Wilms Tumor Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. South Korea Wilms Tumor Protein Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. South Korea Wilms Tumor Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. India Wilms Tumor Protein Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. India Wilms Tumor Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Australia Wilms Tumor Protein Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. Australia Wilms Tumor Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Taiwan Wilms Tumor Protein Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Taiwan Wilms Tumor Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Indonesia Wilms Tumor Protein Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Indonesia Wilms Tumor Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Thailand Wilms Tumor Protein Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Thailand Wilms Tumor Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Malaysia Wilms Tumor Protein Sales Growth Rate (2015-2020) (K Pcs)
Figure 82. Malaysia Wilms Tumor Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Philippines Wilms Tumor Protein Sales Growth Rate (2015-2020) (K Pcs)
Figure 84. Philippines Wilms Tumor Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Vietnam Wilms Tumor Protein Sales Growth Rate (2015-2020) (K Pcs)
Figure 86. Vietnam Wilms Tumor Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 87. Asia Pacific Wilms Tumor Protein Market Share by Type in 2019
Figure 88. Asia Pacific Wilms Tumor Protein Market Share by Application in 2019
Figure 89. Latin America Wilms Tumor Protein Sales Growth Rate 2015-2020 (K Pcs)
Figure 90. Latin America Wilms Tumor Protein Revenue Growth Rate 2015-2020 (US$ Million)
Figure 91. Latin America Wilms Tumor Protein Sales Market Share by Country in 2019
Figure 92. Latin America Wilms Tumor Protein Revenue Market Share by Country in 2019
Figure 93. Mexico Wilms Tumor Protein Sales Growth Rate (2015-2020) (K Pcs)
Figure 94. Mexico Wilms Tumor Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Brazil Wilms Tumor Protein Sales Growth Rate (2015-2020) (K Pcs)
Figure 96. Brazil Wilms Tumor Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Argentina Wilms Tumor Protein Sales Growth Rate (2015-2020) (K Pcs)
Figure 98. Argentina Wilms Tumor Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 99. Latin America Wilms Tumor Protein Market Share by Type in 2019
Figure 100. Latin America Wilms Tumor Protein Market Share by Application in 2019
Figure 101. Middle East and Africa Wilms Tumor Protein Sales Growth Rate 2015-2020 (K Pcs)
Figure 102. Middle East and Africa Wilms Tumor Protein Revenue Growth Rate 2015-2020 (US$ Million)
Figure 103. Middle East and Africa Wilms Tumor Protein Sales Market Share by Country in 2019
Figure 104. Middle East and Africa Wilms Tumor Protein Revenue Market Share by Country in 2019
Figure 105. Turkey Wilms Tumor Protein Sales Growth Rate (2015-2020) (K Pcs)
Figure 106. Turkey Wilms Tumor Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Saudi Arabia Wilms Tumor Protein Sales Growth Rate (2015-2020) (K Pcs)
Figure 108. Saudi Arabia Wilms Tumor Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. U.A.E Wilms Tumor Protein Sales Growth Rate (2015-2020) (K Pcs)
Figure 110. U.A.E Wilms Tumor Protein Revenue Growth Rate (2015-2020) (US$ Million)
Figure 111. Middle East and Africa Wilms Tumor Protein Market Share by Type in 2019
Figure 112. Middle East and Africa Wilms Tumor Protein Market Share by Application in 2019
Figure 113. North America Wilms Tumor Protein Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 114. North America Wilms Tumor Protein Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Europe Wilms Tumor Protein Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 116. Europe Wilms Tumor Protein Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Asia Pacific Wilms Tumor Protein Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 118. Asia Pacific Wilms Tumor Protein Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Latin America Wilms Tumor Protein Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 120. Latin America Wilms Tumor Protein Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Middle East and Africa Wilms Tumor Protein Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 122. Middle East and Africa Wilms Tumor Protein Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Porter's Five Forces Analysis
Figure 124. Channels of Distribution
Figure 125. Distributors Profiles
Figure 126. Bottom-up and Top-down Approaches for This Report
Figure 127. Data Triangulation
Figure 128. Key Executives Interviewed
ウィルムス腫瘍治療の世界市場（～2026年） Market Analysis and Insights: Global Wilms' Tumor Treatment Market The global Wilms' Tumor Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Wilms' Tumor Treatment Scope and Market Size Wilms' Tumor Treatment m…- 腫瘍治療フィールド（TTField）の世界市場（～2026年） Tumor Treating Field (TTField) is an anticancer treatment which disrupts the tumor cells mitosis. Tumor Treating Field is a low intensity technique which disrupts the division of cells through physical interaction of molecules during mitosis in tumor cancer. North America is projected to hold larges…
- 交流電場腫瘍治療の世界市場（～2026年） Alternating electric field tumor therapy is an anticancer treatment which disrupts the tumor cells mitosis. Alternating electric field therapy is a low intensity technique which disrupts the division of cells through physical interaction of molecules during mitosis in tumor cancer. The alternating e…
- 循環腫瘍細胞（CTC）予後技術の世界市場（～2026年） Circulating tumor cells (CTCs) are specialized rare cells, which have been shed from a primary solid tumor of the body and circulate in the vasculature system of the body, eventually causing metastasis. CTCs act as the seeds for successive development of additional metastatic tumors in distant organ…
- 循環腫瘍細胞（CTC）＆がん幹細胞の世界市場（～2026年） The tumor cells which have shed into lymphatic system and circulated over the body through blood circulation are called as circulating tumor cells. Circulating tumor cells may comprise seeds for metastasis. Stem cells are the type of cells that can differentiate into specialized cells and have the c…